Skip to main content
TipRanks
Go Ultimate75% OFF

Paradigm Biopharmaceuticals (PAR) Share Forecast & Price Target

46 Followers
See the Price Targets and Ratings of:

PAR Analyst Ratings

Currently, no data available

PAR Stock 12 Month Forecast

There Are No Analyst Ratings for PAR In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for AU:PAR
Price TargetArticle
Bell PotterAU$0.45→AU$0.42buy71.43%UpsideReiterated08/03/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Paradigm Biopharmaceuticals

3 Months
John Hester
John HesterBell Potter
Success Rate6/10 ratings generated profit
60%
Average Return
+4.94%

Copying John Hester's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +4.94% per trade.

1 Year
John Hester
John HesterBell Potter
Success Rate0/8 ratings generated profit
0%
Average Return
-38.92%

Copying John Hester's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -38.92% per trade.

2 Years
John Hester
John HesterBell Potter
Success Rate0/6 ratings generated profit
0%
Average Return
-75.85%

Copying John Hester's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -75.85% per trade.

PAR Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for PAR
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy12110
Buy00000
Hold00000
Sell00000
Strong Sell00000
total12110

In the current month, PAR has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PAR average Analyst price target in the past 3 months is ―.

PAR Financial Forecast

AU$-2AU$-1.5AU$-1AU$-0.5AU$0Q4 2025Q4 2026Q2 2027
ConsensusAU$-0.10

PAR Earnings Forecast

Next quarter’s earnings estimate for PAR is -AUD 0.10 with a range of ― to ―. The previous quarter’s EPS was -AUD 0.10. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

AU$16,699AU$26,274.5AU$35,850AU$45,425.5AU$55,001Q4 2025Q4 2026Q2 2027
ConsensusAU$55K

PAR Sales Forecast

Next quarter’s sales forecast for PAR is AUD 55.00K with a range of ― to ―. The previous quarter’s sales results were AUD 55.00K. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

PAR Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Paradigm Biopharmaceuticals?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Paradigm Biopharmaceuticals?
To buy shares of AU:PAR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.